MY8500757A - Androstane carbothioates - Google Patents

Androstane carbothioates

Info

Publication number
MY8500757A
MY8500757A MY757/85A MY8500757A MY8500757A MY 8500757 A MY8500757 A MY 8500757A MY 757/85 A MY757/85 A MY 757/85A MY 8500757 A MY8500757 A MY 8500757A MY 8500757 A MY8500757 A MY 8500757A
Authority
MY
Malaysia
Prior art keywords
group
alpha
compounds
hydrogen
formula
Prior art date
Application number
MY757/85A
Other languages
English (en)
Inventor
Gordon Hanley Phillipps
Brian Macdonald Bain
Christopher Williamson
Ian Philikp Steeples
Stuart Bruce Laing
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MY8500757A publication Critical patent/MY8500757A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY757/85A 1980-02-15 1985-12-30 Androstane carbothioates MY8500757A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8005174 1980-02-15
GB8013339 1980-04-23

Publications (1)

Publication Number Publication Date
MY8500757A true MY8500757A (en) 1985-12-31

Family

ID=26274505

Family Applications (1)

Application Number Title Priority Date Filing Date
MY757/85A MY8500757A (en) 1980-02-15 1985-12-30 Androstane carbothioates

Country Status (23)

Country Link
KR (1) KR850000969B1 (es)
AT (1) AT395427B (es)
AU (1) AU544517B2 (es)
BG (1) BG60700B2 (es)
CH (2) CH651307A5 (es)
CZ (1) CZ281275B6 (es)
DE (2) DE3153379C2 (es)
DK (1) DK147022C (es)
ES (5) ES8207194A1 (es)
FI (1) FI70904C (es)
FR (2) FR2477156A1 (es)
HK (1) HK58385A (es)
IE (1) IE51394B1 (es)
IT (1) IT1170717B (es)
KE (1) KE3526A (es)
MX (1) MX9202717A (es)
MY (1) MY8500757A (es)
NL (2) NL191792C (es)
NZ (1) NZ196260A (es)
PT (1) PT72502B (es)
SE (1) SE452468B (es)
SG (1) SG36885G (es)
SK (1) SK403491A3 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817929B (en) * 1980-12-22 1982-10-27 Upjohn Co 5alpha-and 5beta-androstane-17beta-carboxylates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1436549A (en) * 1972-06-15 1976-05-19 Glaxo Lab Ltd 17beta-mercaptocarbonyl-3alpha-hydroxy-steroids and their esters
GB1438940A (en) * 1972-07-19 1976-06-09 Glaxo Lab Ltd 17beta-haloalkoxycarbonyl-17alpha-oxysteroids
GB1514476A (en) * 1974-08-30 1978-06-14 Glaxo Lab Ltd Alkyl and haloalkyl androst-4-ene and androsta-1,4-diene-17beta-carboxylates
US4188385A (en) * 1978-04-05 1980-02-12 Syntex (U.S.A.) Inc. Thioetianic acid derivatives
GB1580517A (en) * 1978-04-06 1980-12-03 Fowler I Crutches

Also Published As

Publication number Publication date
CZ403491A3 (en) 1994-03-16
ES524985A0 (es) 1985-01-01
SK278140B6 (en) 1996-02-07
FR2485542A1 (fr) 1981-12-31
KE3526A (en) 1985-06-07
NL8100707A (nl) 1981-09-16
ES8502447A1 (es) 1985-01-01
ES532055A0 (es) 1985-10-16
SE8101010L (sv) 1981-08-16
ES8600936A1 (es) 1985-10-16
FI810444L (fi) 1981-08-16
NL191792B (nl) 1996-04-01
NL960029I1 (nl) 1997-02-03
MX9202717A (es) 1992-06-30
ES518161A0 (es) 1984-01-16
FR2477156A1 (fr) 1981-09-04
DE3105307A1 (de) 1981-12-10
ATA67481A (de) 1992-05-15
DK147022C (da) 1984-08-27
PT72502A (en) 1981-03-01
NL960029I2 (nl) 1997-04-01
IT1170717B (it) 1987-06-03
AU6729881A (en) 1981-08-20
NZ196260A (en) 1983-11-30
PT72502B (en) 1982-02-05
KR830005262A (ko) 1983-08-03
FI70904C (fi) 1986-10-27
BG60700B2 (bg) 1995-12-29
CH644615A5 (de) 1984-08-15
IE810282L (en) 1981-08-15
FI70904B (fi) 1986-07-18
ES499394A0 (es) 1982-09-01
ES8305379A1 (es) 1983-04-01
ES8402317A1 (es) 1984-01-16
IT8147792A0 (it) 1981-02-13
FR2485542B1 (es) 1983-06-10
KR850000969B1 (ko) 1985-07-02
SE452468B (sv) 1987-11-30
DE3153379C2 (es) 1992-11-19
AU544517B2 (en) 1985-06-06
CZ281275B6 (cs) 1996-08-14
NL191792C (nl) 1996-08-02
SG36885G (en) 1985-11-15
DK62381A (da) 1981-08-16
SK403491A3 (en) 1996-02-07
FR2477156B1 (es) 1984-11-16
AT395427B (de) 1992-12-28
ES8207194A1 (es) 1982-09-01
CH651307A5 (de) 1985-09-13
ES509539A0 (es) 1983-04-01
HK58385A (en) 1985-08-16
DE3105307C2 (es) 1988-09-29
DK147022B (da) 1984-03-19
IE51394B1 (en) 1986-12-24

Similar Documents

Publication Publication Date Title
DK159757C (da) Anvendelse af naphthalenderivater til fremstilling af et medikament til behandling eller profylakse af inflammation ved topisk administration og farmaceutisk praeparat til topisk anvendelse indeholdende naphthalenderivaterne
ES8607252A1 (es) Procedimiento para preparar derivados de imidazol
ES8608535A1 (es) Procedimiento para preparar una composicion para el tratamiento topico de acne
ES8300785A1 (es) Procedimiento de preparar esteroides e intermedios de este- roides antiinflamatorios
JPS5366442A (en) Antitumors
SE8100134L (sv) Terpenoider, forfaranden for framstellning av desamma och farmaceutiska kompositioner innehallande desamma
FI842815A0 (fi) Foerening och komposition foer terapeutisk eller diagnostisk anvaendning och terapeutisk behandlingsmetod.
HK58385A (en) Androstane carbothioates
JPS57206610A (en) Anti-inflammatory analgesic solution for external use
FR2433553A1 (fr) Resines de polyesters insatures, non inhibees par l'oxygene de l'air, leur preparation et leurs utilisations
JPS5422331A (en) Preparation of quinones
JPS51143039A (en) An adhesive composition
JPS54125620A (en) Preparation of diazomethane derivative
ES469513A1 (es) Procedimiento para preparar nuevos derivados de pregn-4-eno.
GB1310741A (en) Anthraquinone dyestuffs
SE7904080L (sv) Terminal-bifunktionella xylitderivat
JPS5430108A (en) Diyne-type polyprenyl alcohol and hypotensive agent containing the same
DE3469734D1 (en) Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom
JPS5490145A (en) 4-chloromethylsulfonyl-2,6-dinitrohalogenobenzene derivative, and algicide containing the same
JPS5675429A (en) Anti-inflammatory agent containing ethyl piperidylacetylaminobenzoate
JPS5429327A (en) Bispiropirazine compound, its preparation, and its use as pigment